Health Care & Life Sciences » Pharmaceuticals | Crescita Therapeutics Inc.

Crescita Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
830.00
228.00
3,504.00
12,014.00
16,628
Cost of Goods Sold (COGS) incl. D&A
579.00
13.00
2,717.00
6,007.00
6,556
Gross Income
251.00
215.00
787.00
6,007.00
10,072
SG&A Expense
13,729.00
7,611.00
15,491.00
12,196.00
10,109
EBIT
13,478.00
-
-
6,189.00
37
Unusual Expense
1,202.00
-
-
4,591.00
1,105
Non Operating Income/Expense
131.00
29.00
230.00
96.00
74
Interest Expense
52.00
40.00
123.00
446.00
603
Pretax Income
14,601.00
7,465.00
14,933.00
11,258.00
649
Income Tax
-
-
295.00
-
1,773
Consolidated Net Income
14,601.00
7,465.00
14,638.00
11,258.00
2,422
Net Income
14,601.00
7,465.00
14,638.00
11,258.00
2,422
Net Income After Extraordinaries
14,601.00
518.00
12,392.00
11,053.00
2,448
Net Income Available to Common
14,601.00
15,448.00
16,765.00
11,463.00
2,396
EPS (Basic)
1.20
1.33
1.30
0.77
0.12
Basic Shares Outstanding
12,173.30
11,578.80
12,982.90
14,794.00
19,706.50
EPS (Diluted)
1.20
1.33
1.30
0.77
0.12
Diluted Shares Outstanding
12,173.30
11,578.80
12,982.90
14,794.00
19,706.50
EBITDA
13,178.00
7,383.00
14,322.00
5,028.00
1,109
Non-Operating Interest Income
-
-
124.00
64.00
110

About Crescita Therapeutics

View Profile
Address
2805 Place Louis-R Renaud
Laval Québec H7V 0A3
Canada
Employees -
Website http://www.crescitatherapeutics.com
Updated 07/08/2019
Crescita Therapeutics, Inc. is a dermatology company, which engages in the provisio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases. It operates tgrough the following geographical segments: Canada, United States, Europe, and Other Foreign Countries. The company was founded in 2016 and is headquartered in Mississauga, Canada.